NeoBiotechnologies develops and manufactures monoclonal, multiclonal, and recombinant antibodies for cancer and biomedical research.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see NeoBiotechnologies →Already a subscriber? Sign in
Xcout Intel tracks NeoBiotechnologies continuously — this profile deepens as new filings, funding, people and hiring data arrive.